Bregni, Giacomo, et al. “Rationale and Design of REGINA, a Phase II Trial of Neoadjuvant Regorafenib, Nivolumab, and Short-Course Radiotherapy in Stage II and III Rectal Cancer”. Acta Oncologica, vol. 60, no. 4, Apr. 2021, pp. 549-53, doi:10.1080/0284186X.2020.1871067.